MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients

PLoS ONE - United States
doi 10.1371/journal.pone.0105698
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Efficacy of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients Stratified by HbA1c Levels

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2015English

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences
2016English

Predicting Chronic Comorbid Conditions of Type 2 Diabetes in Newly-Diagnosed Diabetic Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Dynamic Thiol/Disulfide Homeostasis in Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Endocrine Abstracts
2015English

High Prevalence of the Metabolic Syndrome Among Newly Diagnosed Type 2 Diabetes Patients in Denmark

Endocrine Abstracts
2013English

The Level of Netrin-1 Is Decreased in Newly Diagnosed Type 2 Diabetes Mellitus Patients

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2016English

Lipid Profiling Reveals Different Therapeutic Effects of Metformin and Glipizide in Patients With Type 2 Diabetes and Coronary Artery Disease

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Diabetic Peripheral Neuropathy and Sudomotor Dysfunction in Saudi Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Journal of Diabetes, Metabolic Disorders & Control
2017English

Metformin in Patients With Type 2 Diabetes and Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy